KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Long-Term Debt Issuances (2017 - 2018)

Sarepta Therapeutics has reported Long-Term Debt Issuances over the past 4 years, most recently at $18.2 million for Q4 2018.

  • Quarterly results put Long-Term Debt Issuances at $18.2 million for Q4 2018, down 96.64% from a year ago — trailing twelve months through Dec 2023 was $18.2 million (down 70.97% YoY), and the annual figure for FY2022 was $1.1 billion, changed.
  • Long-Term Debt Issuances for Q4 2018 was $18.2 million at Sarepta Therapeutics, down from $44.4 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for SRPT hit a ceiling of $540.4 million in Q4 2017 and a floor of -$133000.0 in Q3 2015.
  • Median Long-Term Debt Issuances over the past 3 years was $44.4 million (2018), compared with a mean of $110.9 million.
  • Peak annual rise in Long-Term Debt Issuances hit 96.64% in 2018, while the deepest fall reached 96.64% in 2018.
  • Sarepta Therapeutics' Long-Term Debt Issuances stood at $399000.0 in 2015, then skyrocketed by 135333.58% to $540.4 million in 2017, then crashed by 96.64% to $18.2 million in 2018.
  • The last three reported values for Long-Term Debt Issuances were $18.2 million (Q4 2018), $44.4 million (Q3 2018), and $77.1 million (Q2 2018) per Business Quant data.